PPTS Portal Home

Revised 2022 (CSC/BOC)

Document Navigator

Document Navigator

ACR–ARS PRACTICE PARAMETER FOR THE PERFORMANCE OF TOTAL BODY IRRADIATION

PREAMBLE

I.

INTRODUCTION

II.

PROCESS OF TBI

II.

PROCESS OF TBI

A.

Clinical Evaluation

II.

PROCESS OF TBI

B.

Informed Consent

II.

PROCESS OF TBI

C.

Treatment Planning

II.

PROCESS OF TBI

D.

Simulation of Treatment

II.

PROCESS OF TBI

E.

Calculations

II.

PROCESS OF TBI

F.

Treatment Aids and Imaging

II.

PROCESS OF TBI

G.

Treatment Delivery

III.

QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL

III.

QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL

A.

Radiation Oncologist

III.

QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL

B.

Qualified Medical Physicist

III.

QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL

C.

Dosimetrist

III.

QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL

D.

Radiation Therapist

III.

QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL

E.

Nurse

IV.

PATIENT AND PERSONEL SAFETY

V.

DOCUMENTATION

VI.

EQUIPMENT SPECIFICATIONS

VII.

QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION

SUMMARY

ACKNOWLEDGEMENTS

REFERENCES

1. Wong JYC, Filippi AR, Dabaja BS, Yahalom J, Specht L. Total Body Irradiation: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG). Int J Radiat Oncol Biol Phys. 2018 Jul 01;101(3):S0360-3016(18)30749-1.
2. Phelan R, Arora, M., Chen, M. Current use and outcome of hematopoietic stem cell transplantation: CIBMTR US summary slides, 2020. 2020.
3. Bredeson C, LeRademacher J, Kato K, et al. Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation. Blood. 2013 Dec 05;122(24):3871-8.
4. Chen YB, Lane AA, Logan B, et al. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2015 Jun;21(6):1046-1053.
5. Copelan EA, Avalos BR, Ahn KW, et al. Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation. Biol Blood Marrow Transplant. 2015 Mar;21(3):S1083-8791(14)01410-4.
6. Copelan EA, Hamilton BK, Avalos B, et al. Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI. Blood. 2013 Dec 05;122(24):3863-70.
7. Eroglu C, Pala C, Kaynar L, et al. Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant. Leuk Lymphoma. 2013 Nov;54(11):2474-9.
8. Nagler A, Rocha V, Labopin M, et al. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation. J Clin Oncol. 2013 Oct 01;31(28):3549-56.
9. Uberti JP, Agovi MA, Tarima S, et al. Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia. Bone Marrow Transplant. 2011 Jan;46(1):34-43.
10. Barker C, Wolden SL. Total Body Irradiation. In: Leibel SA, Phillips TL, ed. Textbook of Radiation Oncology. 2nd ed. Philadelphia, Pa: WB Saunders; 2010.
11. Alyea E, Neuberg D, Mauch P, et al. Effect of total body irradiation dose escalation on outcome following T-cell-depleted allogeneic bone marrow transplantation. Biol Blood Marrow Transplant. 2002;8(3):139-44.
12. Kelsey CR, Horwitz ME, Chino JP, et al. Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors. Int J Radiat Oncol Biol Phys. 2011 Nov 01;81(3):812-8.
13. Kelsey CR, Scott JM, Lane A, et al. Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study. Bone Marrow Transplant. 2014 Oct;49(10):1330-6.
14. Marks DI, Forman SJ, Blume KG, et al. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transplant. 2006 Apr;12(4):438-53.
15. Marnitz S, Zich A, Martus P, et al. Long-term results of total body irradiation in adults with acute lymphoblastic leukemia. Strahlenther Onkol. 2014 May;190(5):453-8.
16. Deeg HJ, Sullivan KM, Buckner CD, et al. Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation. Bone Marrow Transplant. 1986 Dec;1(2):151-7.
17. Thomas ED, Clift RA, Hersman J, et al. Marrow transplantation for acute nonlymphoblastic leukemic in first remission using fractionated or single-dose irradiation. Int J Radiat Oncol Biol Phys. 1982 May;8(5):817-21.
18. Cosset JM, Socié G, Girinsky T, Dubray B, Fourquet A, Gluckman E. Radiobiological and Clinical Bases for Total Body Irradiation in the Leukemias and Lymphomas. Semin Radiat Oncol. 1995 Oct;5(4):301-315.
19. Cowen D, Richaud P, Marit G, et al. Regimen-related toxicity in patients undergoing BMT with total body irradiation using a sweeping beam technique. Bone Marrow Transplant. 1992 Dec;10(6):515-9.
20. Gerig LH, Szanto J, Bichay T, Genest P. A translating-bed technique for total-body irradiation. Phys Med Biol. 1994 Jan;39(1):19-35.
21. Girinsky T, Socie G, Ammarguellat H, et al. Consequences of two different doses to the lungs during a single dose of total body irradiation: results of a randomized study on 85 patients. Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):821-4.
22. Rhee JG, Song CW, Kim TH, Levitt SH. Effect of fractionation and rate of radiation dose on human leukemic cells, HL-60. Radiat Res. 1985 Mar;101(3):519-27.
23. Tarbell NJ, Amato DA, Down JD, Mauch P, Hellman S. Fractionation and dose rate effects in mice: a model for bone marrow transplantation in man. Int J Radiat Oncol Biol Phys. 1987 Jul;13(7):1065-9.
24. Abugideiri M, Nanda RH, Butker C, et al. Factors Influencing Pulmonary Toxicity in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation in the Setting of Total Body Irradiation-Based Myeloablative Conditioning. Int J Radiat Oncol Biol Phys. 2016 Feb 01;94(2):S0360-3016(15)26651-5.
25. Carruthers SA, Wallington MM. Total body irradiation and pneumonitis risk: a review of outcomes. Br J Cancer. 2004 Jun 01;90(11):2080-4.
26. Gao RW, Weisdorf DJ, DeFor TE, Ehler E, Dusenbery KE. Influence of Total Body Irradiation Dose Rate on Idiopathic Pneumonia Syndrome in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation. Int J Radiat Oncol Biol Phys. 2019 Jan 01;103(1):S0360-3016(18)33726-X.
27. Kim DY, Kim IH, Yoon SS, Kang HJ, Shin HY, Kang HC. Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation. Radiat Oncol. 2018 Sep 18;13(1):180.
28. Kim TH, Rybka WB, Lehnert S, Podgorsak EB, Freeman CR. Interstitial pneumonitis following total body irradiation for bone marrow transplantation using two different dose rates. Int J Radiat Oncol Biol Phys. 1985 Jul;11(7):1285-91.
29. Ozsahin M, Belkacémi Y, Pène F, et al. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation. Int J Radiat Oncol Biol Phys. 1996 Jan 01;34(1):71-7.
30. Girinsky T, Benhamou E, Bourhis JH, et al. Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies. J Clin Oncol. 2000 Mar;18(5):981-6.
31. Oya N, Sasai K, Tachiiri S, et al. Influence of radiation dose rate and lung dose on interstitial pneumonitis after fractionated total body irradiation: acute parotitis may predict interstitial pneumonitis. Int J Hematol. 2006 Jan;83(1):86-91.
32. Ozsahin M, Belkacemi Y, Pene F, et al. Total-body irradiation and cataract incidence: a randomized comparison of two instantaneous dose rates. Int J Radiat Oncol Biol Phys. 1994 Jan 15;28(2):343-7.
33. Sampath S, Schultheiss TE, Wong J. Dose response and factors related to interstitial pneumonitis after bone marrow transplant. Int J Radiat Oncol Biol Phys. 2005 Nov 01;63(3):876-84.
34. Baron F, Maris MB, Sandmaier BM, et al. Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. J Clin Oncol. 2005 Mar 20;23(9):1993-2003.
35. Hegenbart U, Niederwieser D, Sandmaier BM, et al. Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors. J Clin Oncol. 2006 Jan 20;24(3):444-53.
36. Laport GG, Sandmaier BM, Storer BE, et al. Reduced-intensity conditioning followed by allogeneic hematopoietic cell transplantation for adult patients with myelodysplastic syndrome and myeloproliferative disorders. Biol Blood Marrow Transplant. 2008 Feb;14(2):246-55.
37. Stelljes M, Bornhauser M, Kroger M, et al. Conditioning with 8-Gy total body irradiation and fludarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia. Blood. 2005 Nov 01;106(9):3314-21.
38. Tomblyn M, Brunstein C, Burns LJ, et al. Similar and promising outcomes in lymphoma patients treated with myeloablative or nonmyeloablative conditioning and allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008 May;14(5):538-45.
39. Baron F, Storb R, Storer BE, et al. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation. J Clin Oncol. 2006 Sep 01;24(25):4150-7.
40. Gyurkocza B, Cao TM, Storb RF, et al. Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts. Biol Blood Marrow Transplant. 2009 Oct;15(10):1314-22.
41. Buchali A, Feyer P, Groll J, Massenkeil G, Arnold R, Budach V. Immediate toxicity during fractionated total body irradiation as conditioning for bone marrow transplantation. Radiother Oncol. 2000 Feb;54(2):157-62.
42. Matsuoka S, Okamoto S, Watanabe R, et al. Granisetron plus dexamethasone versus granisetron alone in the prevention of vomiting induced by conditioning for stem cell transplantation: a prospective randomized study. Int J Hematol. 2003 Jan;77(1):86-90.
43. Peters SG, Afessa B. Acute lung injury after hematopoietic stem cell transplantation. Clin Chest Med. 2005 Dec;26(4):561-9, vi.
44. Esiashvili N, Lu X, Ulin K, et al. Higher Reported Lung Dose Received During Total Body Irradiation for Allogeneic Hematopoietic Stem Cell Transplantation in Children With Acute Lymphoblastic Leukemia Is Associated With Inferior Survival: A Report from the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2019 Jul 01;104(3):S0360-3016(19)30266-4.
45. Wadleigh M, Ho V, Momtaz P, Richardson P. Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr Opin Hematol. 2003 Nov;10(6):451-62.
46. Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: epidemiology, pathogenesis, and treatment. J Am Soc Nephrol. 2006 Jul;17(7):1995-2005.
47. Chemaitilly W, Boulad F, Heller G, et al. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant. 2007 Jul;40(1):29-35.
48. Mertens AC, Ramsay NK, Kouris S, Neglia JP. Patterns of gonadal dysfunction following bone marrow transplantation. Bone Marrow Transplant. 1998 Aug;22(4):345-50.
49. Armenian SH, Sun CL, Vase T, et al. Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease. Blood. 2012 Nov 29;120(23):4505-12.
50. Künkele A, Engelhard M, Hauffa BP, et al. Long-term follow-up of pediatric patients receiving total body irradiation before hematopoietic stem cell transplantation and post-transplant survival of >2 years. Pediatr Blood Cancer. 2013 Nov;60(11):1792-7.
51. Rizzo JD, Curtis RE, Socié G, et al. Solid cancers after allogeneic hematopoietic cell transplantation. Blood. 2009 Jan 29;113(5):1175-83.
52. Bizzarri C, Pinto RM, Ciccone S, Brescia LP, Locatelli F, Cappa M. Early and progressive insulin resistance in young, non-obese cancer survivors treated with hematopoietic stem cell transplantation. Pediatr Blood Cancer. 2015 Sep;62(9):1650-5.
53. Oudin C, Auquier P, Bertrand Y, et al. Metabolic syndrome in adults who received hematopoietic stem cell transplantation for acute childhood leukemia: an LEA study. Bone Marrow Transplant. 2015 Nov;50(11):1438-44.
54. Van Dyk J, Galvin JM, Glasgow GP, Podgorsak EB. AAPM Report No. 17: The physical aspects of total and half body photon irradiation. 1986. http://www.aapm.org/pubs/reports/RPT_17.pdf. .
55. Khan FM, Williamson JF, Sewchand W, Kim TH. Basic data for dosage calculation and compensation. Int J Radiat Oncol Biol Phys. 1980 Jun;6(6):745-51.
56. Ouyang L, Folkerts, M., Zhang, Y., Hrycushko, B., Lamphier, R., Lee, P., Chambers, E., Ramirez, E., Reynolds, R., Yan, Y., Jiang, S., Timmerman, R., Desai, N., Abdulrahman, R., Gu, X.,. Volumetric modulated arc therapy based total body irradiation: Workflow and clinical experience with an indexed rotational immobilization system. Physics and Imaging in Radiation Oncology 2017;4:22-25.
57. Tas B, Durmus IF, Okumus A, et al. Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability. Radiotherapy & Oncology. 129(3):527-533, 2018 12.
58. American College of Radiology. ACR-ARS Practice Parameter for Communication: Radiation Oncology. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=199+&releaseId=2
59. American College of Radiology. ACR-ARS Practice Parameter on Informed Consent- Radiation Oncology. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=141+&releaseId=2
60. Dandapani S.V. WJYC. Modern Total Body Irradiation (TBI): Intensity-Modulated Radiation Treatment (IMRT): Springer, Cham; 2020.
61. Della Volpe A, Ferreri AJ, Annaloro C, et al. Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation. Int J Radiat Oncol Biol Phys. 2002 Feb 01;52(2):483-8.
62. Soule BP, Simone NL, Savani BN, et al. Pulmonary function following total body irradiation (with or without lung shielding) and allogeneic peripheral blood stem cell transplant. Bone Marrow Transplant. 2007 Sep;40(6):573-8.
63. Esiashvili N, Xiaomin, L., Hunger, S., Merchant, T., Brown, P., Wall, D., . Association of higher lung dose received during total body irradiation for allogeneic hematopoetic stem cell transplantation in children with acute lymphoblastic leukemia with inferior progression-free and overall survival: A report from the Children’s Oncology Group. Journal of Clinical Oncology 2015;33:10030.
64. Chi P, Pinnix C, Dabaja B, Wang C, Aristophanous M, Tung S. Simple field-in-field technique for total body irradiation in large patients. Med Phys 2014;41:318.
65. Ding GX, Alaei P, Curran B, et al. Image guidance doses delivered during radiotherapy: Quantification, management, and reduction: Report of the AAPM Therapy Physics Committee Task Group 180. Med Phys. 2018 May;45(5):e84-e99.
66. American College of Radiology. ACR-ARS Practice Parameter for Radiation Oncology. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=200+&releaseId=2
67. American College of Radiology. ACR Practice Parameter for Continuing Medical Education. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=130+&releaseId=2
68. Hui SK, Kapatoes J, Fowler J, et al. Feasibility study of helical tomotherapy for total body or total marrow irradiation. Med Phys. 2005 Oct;32(10):3214-24.
69. Springer A, Hammer J, Winkler E, et al. Total body irradiation with volumetric modulated arc therapy: Dosimetric data and first clinical experience. Radiat. oncol.. 11:46, 2016 Mar 22.
70. Wong JY, Rosenthal J, Liu A, Schultheiss T, Forman S, Somlo G. Image-guided total-marrow irradiation using helical tomotherapy in patients with multiple myeloma and acute leukemia undergoing hematopoietic cell transplantation. Int J Radiat Oncol Biol Phys. 2009 Jan 01;73(1):273-9.